US Patent 7923447 Parenteral solutions containing metolazone
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+338 characters)
Article
Patent abstract
Disclosed herein are parenteral solutions containing 7-halo-1,2,3,4-tetrahydro-3-aryl-6-quinazoline sulfonamide in N,N-dimethylactamide, polyethylene glycol and D5W useful in the treatment of hypertension, heart failure and renal disease leading to edematous states. Also disclosed are methods for preparing such solutions.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07923447 Parenteral solutions containing metolazone US Patent 7923447 Parenteral solutions containing metolazone
Infobox
Patent Number
0792344700
Patent Number
792344700
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 Mar, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
079234470
Date of Patent
April 12, 2011
0Patent Application Number
120770080
Date Filed
March 17, 2008
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
079234470
Date of Patent
April 12, 2011
0Patent Application Number
120770080
Date Filed
March 17, 2008
0Official Website
Patent Primary Examiner
Edits on 19 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07923447 Parenteral solutions containing metolazone
Infobox
Is a
Patent jurisdiction
Patent number
07923447
Date of patent
April 12, 2011
Patent application number
12077008
Date Filed
March 17, 2008
Patent primary examiner
Find more entities like US Patent 7923447 Parenteral solutions containing metolazone
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.